WHO/UNICEF/UNFPA JOINT STATEMENT
Appropriate Storage and Management
of Oxytocin – a Key Commodity
for Maternal Health
WHO/UNICEF/UNFPA have issued a joint statement regarding the management of oxytocin, a medicine essential to the prevention and treatment of postpartum haemorrhage as well as other indications. The management of oxytocin is critical to ensuring that it is effective when it reaches women, including procurement, cold chain management and clear and consistent labelling. Please read the link to the joint statement for specific details.